GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Appili Therapeutics APLI.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Appili Therapeutics — daily TSX:APLI Delayed

About Appili Therapeutics

Its shares trade on Toronto Stock Exchange under the ticker APLI.TO. It has been listed since 25 June 2019. In the fiscal year to 31 March 2026, it reported revenue of C$244,179 and a net loss of C$4.2m. At that date it held total assets of C$2.0m and shareholders' equity of −C$17.3m.

Appili Therapeutics, Inc. is a pharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. The company is headquartered in Halifax, Nova Scotia. The company went IPO on 2019-06-25. The firm is focused on the acquisition and development of treatments targeting infectious disease. The firm is focused on building and advancing adverse portfolio of anti-infective programs. The Company’s anti-infective portfolio includes ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir. The ATI-2307 is a clinical-stage antifungal candidate in development for severe and difficult-to-treat invasive fungal infections. The ATI-1701 is a vaccine candidate for tularemia. The ATI-1503 is a drug discovery program aimed at generating a class of antibiotics with broad spectrum activity against gram-negative superbugs. The ATI-1501 employs its taste-masked, oral-suspension technology with metronidazole for the patients with difficulty swallowing.

Figures and description from our data supplier, not checked against the company's own report.

More about Appili Therapeutics →

Latest on Appili Therapeutics

Our reporting

We have not reported on Appili Therapeutics yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.05 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Appili Therapeutics's ticker?

Appili Therapeutics trades as APLI.TO on Toronto Stock Exchange, under ISIN CA03783R1073.

What was Appili Therapeutics's last closing price?

We have not recorded a close for this listing yet. The chart above carries pricing from TradingView.

When does Appili Therapeutics next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.